“Drs. Amir Goldkorn, Timothy Triche, and Vinay Duddalwar awarded a new multi-investigator R01 grant from the National Cancer Institute for translational biomarker studies in advanced prostate cancer
This study will be performed using liquid biopsy samples and CT scans prospectively collected in a 5-year NCI SWOG multi-center clinical trial for men with metastatic prostate cancer. The project combines the investigators’ respective expertise in liquid biopsy profiling, targeted sequencing, and radiomic analysis, as well as a first-of-its-kind prostate cancer amplicon sequencing panel co-developed with Thermo Fisher Scientific. These capabilities will be combined to develop new multi-omic signatures for predicting treatment response and tracking disease progression.”
